Annual Cash & Cash Equivalents
$84.31 M
+$26.21 M+45.11%
December 31, 2023
Summary
- As of February 7, 2025, ATRC annual cash & cash equivalents is $84.31 million, with the most recent change of +$26.21 million (+45.11%) on December 31, 2023.
- During the last 3 years, ATRC annual cash & cash equivalents has risen by +$42.37 million (+101.01%).
- ATRC annual cash & cash equivalents is now at all-time high.
Performance
ATRC Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Cash And Cash Equivalents
$130.34 M
+$24.30 M+22.92%
September 30, 2024
Summary
- As of February 7, 2025, ATRC quarterly cash and cash equivalents is $130.34 million, with the most recent change of +$24.30 million (+22.92%) on September 30, 2024.
- Over the past year, ATRC quarterly cash and cash equivalents has increased by +$49.74 million (+61.71%).
- ATRC quarterly cash and cash equivalents is now at all-time high.
Performance
ATRC Quarterly Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash And Cash Equivalents Formula
Cash & Cash Equivalents = Cash + Short-Term Investments
ATRC Cash And Cash Equivalents Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +45.1% | +61.7% |
| 3 y3 years | +101.0% | +226.8% |
| 5 y5 years | +161.6% | +292.8% |
ATRC Cash And Cash Equivalents Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +93.1% | at high | +363.1% |
| 5 y | 5-year | at high | +196.0% | at high | +498.8% |
| alltime | all time | at high | +1892.8% | at high | >+9999.0% |
AtriCure Cash And Cash Equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $130.34 M(+22.9%) |
| Jun 2024 | - | $106.03 M(+63.2%) |
| Mar 2024 | - | $64.97 M(-22.9%) |
| Dec 2023 | $84.31 M(+45.1%) | $84.31 M(+4.6%) |
| Sep 2023 | - | $80.60 M(+19.9%) |
| Jun 2023 | - | $67.24 M(-13.1%) |
| Mar 2023 | - | $77.34 M(+33.1%) |
| Dec 2022 | $58.10 M(+33.1%) | $58.10 M(+19.0%) |
| Sep 2022 | - | $48.82 M(-10.5%) |
| Jun 2022 | - | $54.56 M(+93.9%) |
| Mar 2022 | - | $28.14 M(-35.5%) |
| Dec 2021 | $43.65 M(+4.1%) | $43.65 M(+9.4%) |
| Sep 2021 | - | $39.89 M(-41.0%) |
| Jun 2021 | - | $67.62 M(-20.8%) |
| Mar 2021 | - | $85.38 M(+103.6%) |
| Dec 2020 | $41.94 M(+47.3%) | $41.94 M(+25.7%) |
| Sep 2020 | - | $33.38 M(-62.3%) |
| Jun 2020 | - | $88.52 M(+306.7%) |
| Mar 2020 | - | $21.77 M(-23.6%) |
| Dec 2019 | $28.48 M(-11.6%) | $28.48 M(-14.2%) |
| Sep 2019 | - | $33.18 M(+31.4%) |
| Jun 2019 | - | $25.25 M(+21.8%) |
| Mar 2019 | - | $20.72 M(-35.7%) |
| Dec 2018 | $32.23 M(+47.8%) | $32.23 M(+79.1%) |
| Sep 2018 | - | $18.00 M(+29.8%) |
| Jun 2018 | - | $13.87 M(-34.7%) |
| Mar 2018 | - | $21.23 M(-2.7%) |
| Dec 2017 | $21.81 M(-9.9%) | $21.81 M(+12.2%) |
| Sep 2017 | - | $19.44 M(-7.5%) |
| Jun 2017 | - | $21.01 M(+9.7%) |
| Mar 2017 | - | $19.15 M(-20.9%) |
| Dec 2016 | $24.21 M(+1.9%) | $24.21 M(+50.3%) |
| Sep 2016 | - | $16.11 M(-19.1%) |
| Jun 2016 | - | $19.92 M(-4.1%) |
| Mar 2016 | - | $20.77 M(-12.6%) |
| Dec 2015 | $23.76 M(-16.3%) | $23.76 M(-17.2%) |
| Sep 2015 | - | $28.71 M(-4.2%) |
| Jun 2015 | - | $29.99 M(+27.3%) |
| Mar 2015 | - | $23.56 M(-17.0%) |
| Dec 2014 | $28.38 M | $28.38 M(-20.1%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2014 | - | $35.53 M(-15.4%) |
| Jun 2014 | - | $41.98 M(-38.8%) |
| Mar 2014 | - | $68.64 M(+360.9%) |
| Dec 2013 | $14.89 M(+92.1%) | $14.89 M(-42.3%) |
| Sep 2013 | - | $25.82 M(-16.8%) |
| Jun 2013 | - | $31.04 M(+0.8%) |
| Mar 2013 | - | $30.78 M(+297.1%) |
| Dec 2012 | $7.75 M(-20.6%) | $7.75 M(-5.5%) |
| Sep 2012 | - | $8.20 M(-5.3%) |
| Jun 2012 | - | $8.66 M(-24.2%) |
| Mar 2012 | - | $11.42 M(+17.0%) |
| Dec 2011 | $9.76 M(+130.7%) | $9.76 M(+184.4%) |
| Sep 2011 | - | $3.43 M(-16.5%) |
| Jun 2011 | - | $4.11 M(-46.5%) |
| Mar 2011 | - | $7.69 M(+81.7%) |
| Dec 2010 | $4.23 M(-52.5%) | $4.23 M(+20.0%) |
| Sep 2010 | - | $3.53 M(-48.6%) |
| Jun 2010 | - | $6.85 M(+87.5%) |
| Mar 2010 | - | $3.66 M(-59.0%) |
| Dec 2009 | $8.91 M(-22.2%) | $8.91 M(-15.8%) |
| Sep 2009 | - | $10.57 M(-23.0%) |
| Jun 2009 | - | $13.73 M(+59.5%) |
| Mar 2009 | - | $8.61 M(-24.8%) |
| Dec 2008 | $11.45 M(-11.9%) | $11.45 M(-6.8%) |
| Sep 2008 | - | $12.28 M(+22.5%) |
| Jun 2008 | - | $10.02 M(-23.0%) |
| Mar 2008 | - | $13.01 M(+0.1%) |
| Dec 2007 | $13.00 M(-12.7%) | $13.00 M(-24.5%) |
| Sep 2007 | - | $17.23 M(-37.9%) |
| Jun 2007 | - | $27.74 M(+110.3%) |
| Mar 2007 | - | $13.19 M(-11.4%) |
| Dec 2006 | $14.89 M(-45.7%) | $14.89 M(-5.9%) |
| Sep 2006 | - | $15.82 M(-20.2%) |
| Jun 2006 | - | $19.81 M(-14.1%) |
| Mar 2006 | - | $23.06 M(-15.9%) |
| Dec 2005 | $27.43 M(+430.1%) | $27.43 M(-28.4%) |
| Sep 2005 | - | $38.34 M(+3414.8%) |
| Jun 2005 | - | $1.09 M(-55.5%) |
| Mar 2005 | - | $2.45 M(-52.6%) |
| Dec 2004 | $5.18 M | $5.18 M |
FAQ
- What is AtriCure annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for AtriCure?
- What is AtriCure annual cash & cash equivalents year-on-year change?
- What is AtriCure quarterly cash and cash equivalents?
- What is the all time high quarterly cash and cash equivalents for AtriCure?
- What is AtriCure quarterly cash and cash equivalents year-on-year change?
What is AtriCure annual cash & cash equivalents?
The current annual cash & cash equivalents of ATRC is $84.31 M
What is the all time high annual cash & cash equivalents for AtriCure?
AtriCure all-time high annual cash & cash equivalents is $84.31 M
What is AtriCure annual cash & cash equivalents year-on-year change?
Over the past year, ATRC annual cash & cash equivalents has changed by +$26.21 M (+45.11%)
What is AtriCure quarterly cash and cash equivalents?
The current quarterly cash and cash equivalents of ATRC is $130.34 M
What is the all time high quarterly cash and cash equivalents for AtriCure?
AtriCure all-time high quarterly cash and cash equivalents is $130.34 M
What is AtriCure quarterly cash and cash equivalents year-on-year change?
Over the past year, ATRC quarterly cash and cash equivalents has changed by +$49.74 M (+61.71%)